Filing Details
- Accession Number:
- 0001179110-13-003532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-26 16:13:08
- Reporting Period:
- 2013-02-25
- Filing Date:
- 2013-02-26
- Accepted Time:
- 2013-02-26 16:13:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1204787 | Clive Meanwell | 8 Sylvan Way Parsippany NJ 07054 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-02-25 | 12,303 | $31.17 | 314,049 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold to cover the tax expense associated with the vesting of restricted shares held by Dr. Meanwell pursuant to his Restricted Stock Agreements with the Company.
- The range of prices for the transactions reported on this line is between $31.13 and $31.21 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.